Yusuke Kono
Impact in
- Oncology top 5%
- Inflammatory Biomarkers in Disease Prognosis
- Cancer Immunotherapy and Biomarkers
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Gastric Cancer Management and Outcomes 31
- Metastasis and carcinoma case studies 14
- Oncology 33
- Inflammatory Biomarkers in Disease Prognosis 14
- Cancer Immunotherapy and Biomarkers 10
- Co-authors
- Yoji Fukumoto (38 shared papers)Hiroaki Saito (37 shared papers)Yoshiyuki Fujiwara (46 shared papers)Tomoyuki Matsunaga (43 shared papers)Yuji Shishido (37 shared papers)Takuya Fujita (21 shared papers)Keigo Ashida (18 shared papers)Tomohiro Osaki (24 shared papers)
- Journals
- Biological and Pharmaceutical Bulletin (11 papers)Surgery Today (9 papers)Anticancer Research (5 papers)International Journal of Pharmaceutics (4 papers)Scientific Reports (2 papers)
- Partner nations
- JapanUnited StatesSaudi Arabia
In The Last Decade
Yusuke Kono
88 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 101
- Oncology 509
- Biomaterials 172
- Pharmaceutical Science 69
- Gastroenterology 59
- Immunology 217
Countries citing papers authored by Yusuke Kono
This map shows the geographic impact of Yusuke Kono's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yusuke Kono with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yusuke Kono more than expected).
Fields of papers citing papers by Yusuke Kono
This network shows the impact of papers produced by Yusuke Kono. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yusuke Kono. The network helps show where Yusuke Kono may publish in the future.
Co-authors
The 25 scholars most cited alongside Yusuke Kono, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 93 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 122 | |
| 2 | 2019 | 95 | |
| 3 | 2017 | 76 | |
| 4 | 2018 | 43 | |
| 5 | 2017 | 38 | |
| 6 | 2019 | 35 | |
| 7 | 2013 | 34 | |
| 8 | 2020 | 33 | |
| 9 | 2017 | 29 | |
| 10 | 2014 | 26 | |
| 11 | 2017 | 24 | |
| 12 | 2020 | 23 | |
| 13 | 2017 | 23 | |
| 14 | 2018 | 22 | |
| 15 | 2018 | 21 | |
| 16 | 2012 | 21 | |
| 17 | Postoperative Serum Albumin is a Potential Prognostic Factor for Older Patients with Gastric Cancer. | 2018 | 20 |
| 18 | 2016 | 20 | |
| 19 | 2018 | 20 | |
| 20 | 2018 | 19 |
About Yusuke Kono
Yusuke Kono is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Molecular Biology and Gastroenterology, having authored 93 papers that have together received 1.2k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (31 papers), Nanoparticle-Based Drug Delivery (15 papers), Inflammatory Biomarkers in Disease Prognosis (14 papers), Gastrointestinal Tumor Research and Treatment (14 papers), Metastasis and carcinoma case studies (14 papers), Cancer Immunotherapy and Biomarkers (10 papers), RNA Interference and Gene Delivery (9 papers) and Advanced Drug Delivery Systems (9 papers). The work is most often cited by research in Oncology (509 citations), Biomaterials (172 citations), Pharmaceutical Science (69 citations), Gastroenterology (59 citations) and Immunology (217 citations). Yusuke Kono has collaborated with scholars based in Japan, United States and Saudi Arabia. Frequent co-authors include Yoji Fukumoto, Hiroaki Saito, Yoshiyuki Fujiwara, Tomoyuki Matsunaga, Yuji Shishido, Takuya Fujita, Keigo Ashida, Tomohiro Osaki, Hirohiko Kuroda and Ken‐ichi Ogawara. Their work appears in journals such as Biological and Pharmaceutical Bulletin, Surgery Today, Anticancer Research, International Journal of Pharmaceutics and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.